Blog
RSS FeedPosted by Michael Wonder on 01 Dec 2024
Life changing endometriosis treatment now cheaper
1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...
Posted by Michael Wonder on 01 Dec 2024
Voters clamour for affordable health in election lead-up
30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...
Posted by Michael Wonder on 01 Dec 2024
DUSC utilisation analysis public release documents (June 2024) update
22 November 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 30 Nov 2024
Insurer greed to inflict more financial pain on patients
22 November 2024 - Following Bupa and the Australian Health Services Alliance (AHSA)’s refusal to acknowledge the viability crisis impacting ...
Posted by Michael Wonder on 29 Nov 2024
Update from the PBAC (November 2024)
28 November 2024 - An update from the Chair and Deputy Chair of the PBAC is now available. ...
Posted by Michael Wonder on 27 Nov 2024
Australians benefit from new and expanded medicines on the PBS
20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...
Posted by Michael Wonder on 17 Nov 2024
Establishing Genomics Australia
15 November 2024 - The Albanese Government is establishing a new national body to provide leadership, coordination and expertise so ...
Posted by Michael Wonder on 17 Nov 2024
Evidence of clinical benefit of cancer medicines considered for funding in Australia
14 November 2024 - The objective was to describe the type of evidence and the clinical benefit of cancer medicines ...
Posted by Michael Wonder on 16 Nov 2024
Different models, same results: considerations when choosing between approaches to model cost effectiveness of chimeric antigen receptor T-cell therapy versus standard of care
7 September 2024 - Chimeric antigen-receptor T-cell therapy (CAR-T) is characterised by early phase data at the time of registration, high ...
Posted by Michael Wonder on 16 Nov 2024
Outcome statement - October 2024 DUSC meeting
15 November 2024 - The outcome statement from the October 2024 DUSC meeting is now available. ...
Posted by Michael Wonder on 15 Nov 2024
Public Summary Documents (first time decisions not to recommend and deferrals) - July 2024 PBAC meeting
15 November 2024 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2024 PBAC ...
Posted by Michael Wonder on 13 Nov 2024
How the Morrison Government passed over an Australian company for a US pharmaceutical giant
13 November 2024 - Australia’s audit office will probe the Morrison Government’s $2 billion deal with US pharmaceutical giant Moderna ...
Posted by Michael Wonder on 11 Nov 2024
World leading approach to protect babies from RSV
10 November 2024 - Australian mums and their newborn babies will have free access to the best and most comprehensive ...
Posted by Michael Wonder on 11 Nov 2024
Pharmas allege Government communication breakdown in medicine deferral crisis
10 November 2024 - Labor has failed to plan for the consequences of delaying drug subsidies and left hundreds of ...
Posted by Michael Wonder on 08 Nov 2024
Health officials warn of ‘practical limitations’ to medicine subsidies despite ‘triage’
8 November 2024 - Fears of on-going delays to critical new medicine subsidies have been stoked by a Health Department ...